Results 1 to 10 of about 400,917 (195)
BMC Pharmacology and Toxicology, 2018 Background Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most
Hans Benno Leicht +5 more
doaj +2 more sources
Lupus Anticoagulant Positivity as a Risk Marker for Hemolytic Anemia in Patients with APS [PDF]
MedicinaBackground and Objectives: Thrombocytopenia and hemolytic anemia are common but non-criteria manifestations of antiphospholipid syndrome (APS). However, their relationship with specific immunological profiles remains poorly characterized.
Ji-Hyoun Kang
doaj +2 more sources
The Prevalence of Peripheral Erythrophagocytosis in Pediatric Immune-Mediated Hemolytic Anemia [PDF]
Hematology ReportsBackground: Peripheral erythrophagocytosis appears to be a unique sign of acquired immune-mediated hemolytic anemia. It is said to be rare but its prevalence among patients with autoimmune hemolytic anemia has not been studied.
Anselm Chi-wai Lee
doaj +2 more sources
Annals of Hematology, 2022 COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with angiotensin-converting enzyme 2 (ACE2) receptor, CD147, and erythrocyte Band3 protein ...
H. Al-kuraishy +4 more
semanticscholar +1 more source
Rambam Maimonides Medical Journal, 2021 Gaucher disease (GD) is an autosomal recessive disease characterized by the buildup of glucocerebrosides in macrophages, resulting in the formation of “Gaucher cells.” These cells predominantly infiltrate the liver, spleen, and bone marrow leading to ...
Eliyakim Hershkop +4 more
doaj +1 more source
Autoimmune hemolytic anemia: causes and consequences
Expert Review of Clinical Immunology, 2022 Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold forms, and in primary versus secondary depending on the presence of ...
B. Fattizzo, W. Barcellini
semanticscholar +1 more source
How I treat warm autoimmune hemolytic anemia.
Blood, 2021 Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by IgG autoantibodies, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: A case report
Current Problems in Cancer: Case Reports, 2022 Background: Anaplastic Lymphoma Kinase (ALK) inhibitors are tyrosine kinase inhibitors used as molecular-targeted therapy for non-small cell lung cancers (NSCLC) harbouring ALK translocations.
Robina Aerts +6 more
doaj +1 more source
Traumatic Hemolytic Anemia after Valve Surgery: a Case Report [PDF]
Folia Medica, 2020 Hemolytic anemia is an uncommon complication after mitral valve repair. We present a case of a 55-year-old man who presented with post-operative hemolytic anemia after mitral valve repair with prosthetic ring.
Feridoun Sabzi +2 more
doaj +3 more sources
How I treat microangiopathic hemolytic anemia in patients with cancer
Blood, 2021 Diagnosis and treatment of acquired hemolytic anemia can be challenging. In this How I Treat series, edited by Mario Cazzola, clinical experts discuss their approaches to the treatment of patients with 4 different classes of acquired hemolytic anemia.
M. Thomas, M. Scully
semanticscholar +1 more source